Finally, what we’ve all been waiting for. A groundbreaking medic - a podcast by Ed Chaney

In this episode. Ed and Kim talk with Ken Epstein, CCO & Co-Founder of Cannformatics, regarding this groundbreaking paper and what lies ahead for similar research. In spite of today’s cannabis challenges, Cannformatics, a San Francisco-based biotech startup, is conducting groundbreaking clinical studies to remove the confusion and stigma patients face when looking for medical cannabis to improve wellness. The work focuses on developing Cannabis-Responsive biomarkers that can be used to optimize medical cannabis treatments by providing patients and their physicians with data, similar to the data in a blood test, that shows how medical cannabis treatment is impacting the patient’s condition.

Further episodes of The CBD Ed Show with Ed Chaney

Further podcasts by Ed Chaney

Website of Ed Chaney